Literature DB >> 19801681

The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion.

Khalid Sossey-Alaoui1, Katarzyna Bialkowska, Edward F Plow.   

Abstract

MicroRNAs are small non-coding RNAs that are directly involved in the regulation of gene expression by either translational repression or degradation of target mRNAs. Because of the high level of conservation of the target motifs, known as seed sequences, within the 3'-untranslated regions, a single microRNA can regulate numerous target genes simultaneously, making this class of RNAs a powerful regulator of gene expression. The miR200 family of microRNAs has recently been shown to regulate the process of epithelial to mesenchymal transition during tumor progression and metastasis. Here, we report that the expression of WAVE3, an actin cytoskeleton remodeling and metastasis promoter protein, is regulated by miR200 microRNAs. We show a clear inverse correlation between expression levels of WAVE3 and miR200 microRNAs in invasive versus non-invasive cancer cells. miR200 directly targets the 3'-untranslated regions of the WAVE3 mRNA and inhibits its expression. The miR200-mediated down-regulation of WAVE3 results in a significant reduction in the invasive phenotype of cancer cells, which is specific to the loss of WAVE3 expression. Re-expression of a miR200-resistant WAVE3 reverses miR200-mediated inhibition of cancer cell invasion. Loss of WAVE3 expression downstream of miR200 also results in a dramatic change in cell morphology resembling that of a mesenchymal to epithelial transition. In conclusion, a novel mechanism for the regulation of WAVE3 expression in cancer cells has been identified, which controls the invasive properties and morphology of cancer cells associated with their metastatic potential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801681      PMCID: PMC2785142          DOI: 10.1074/jbc.M109.034553

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  WAVE2 is required for directed cell migration and cardiovascular development.

Authors:  Daisuke Yamazaki; Shiro Suetsugu; Hiroaki Miki; Yuki Kataoka; Shin-Ichi Nishikawa; Takashi Fujiwara; Nobuaki Yoshida; Tadaomi Takenawa
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

2.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

3.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors.

Authors:  Weigang Wang; Sumanta Goswami; Kyle Lapidus; Amber L Wells; Jeffrey B Wyckoff; Erik Sahai; Robert H Singer; Jeffrey E Segall; John S Condeelis
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

Review 5.  The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.

Authors:  Manav Korpal; Yibin Kang
Journal:  RNA Biol       Date:  2008 Jul-Sep       Impact factor: 4.652

6.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

Authors:  Cameron P Bracken; Philip A Gregory; Natasha Kolesnikoff; Andrew G Bert; Jun Wang; M Frances Shannon; Gregory J Goodall
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

8.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 9.  WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement.

Authors:  T Takenawa; H Miki
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

View more
  68 in total

1.  MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.

Authors:  Sarah Jurmeister; Marek Baumann; Aleksandra Balwierz; Ioanna Keklikoglou; Aoife Ward; Stefan Uhlmann; Jitao David Zhang; Stefan Wiemann; Özgür Sahin
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

2.  MicroRNA-34a modulates cytoskeletal dynamics through regulating RhoA/Rac1 cross-talk in chondroblasts.

Authors:  Dongkyun Kim; Jinsoo Song; Sunhyo Kim; Hyang Mi Park; Churl-Hong Chun; Jongkyung Sonn; Eun-Jung Jin
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

3.  MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells.

Authors:  Wei Xia; Jie Li; Liucun Chen; Baochun Huang; Shaohua Li; Guang Yang; Hongmei Ding; Fang Wang; Nongle Liu; Qiang Zhao; Tao Fang; Tao Song; Tianyou Wang; Ningsheng Shao
Journal:  Mol Cell Biochem       Date:  2010-08-04       Impact factor: 3.396

Review 4.  The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

Authors:  Simone Brabletz; Thomas Brabletz
Journal:  EMBO Rep       Date:  2010-08-13       Impact factor: 8.807

Review 5.  microRNAs and EMT in mammary cells and breast cancer.

Authors:  Josephine A Wright; Jennifer K Richer; Gregory J Goodall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-25       Impact factor: 2.673

6.  miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics.

Authors:  Khalid Sossey-Alaoui; Edward F Plow
Journal:  Mol Cancer Res       Date:  2015-10-16       Impact factor: 5.852

7.  miR141 expression is downregulated and negatively correlated with STAT5 expression in esophageal squamous cell carcinoma.

Authors:  Hongwu Tan; Yunfeng Zhu; Jiling Zhang; Lijun Peng; Tao Ji
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

8.  miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.

Authors:  Kelsey Bolin; Nicholas Rachmaninoff; Kea Moncada; Katharine Pula; Jennifer Kennell; Laura Buttitta
Journal:  Dev Biol       Date:  2016-02-21       Impact factor: 3.582

9.  Roles for microRNAs in the regulation of cell adhesion molecules.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  J Cell Sci       Date:  2011-04-01       Impact factor: 5.285

10.  Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis.

Authors:  Khalid Sossey-Alaoui; Elzbieta Pluskota; Gangarao Davuluri; Katarzyna Bialkowska; Mitali Das; Dorota Szpak; Daniel J Lindner; Erinn Downs-Kelly; Cheryl L Thompson; Edward F Plow
Journal:  FASEB J       Date:  2014-01-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.